Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: J Clin Lipidol. 2018 Mar 30;12(4):1061–1071.e7. doi: 10.1016/j.jacl.2018.03.085

Table 1.

Patient characteristics by baseline HDL-c level (in mg/dl) in those with CKD

Variable Overall (N=38377) ≤30 (N=2463) 31–40 (N=7530) 41–50 (N=10369) 51–60 (N=8223) >60 (N=9792) p-value
Age 71.7+11.2 68.8+12.1 70.3+11.2 71.4+11.1 72.6+10.9 73.1+11.2 <0.001a
Male gender, % 44.2 70.2 64.7 49.6 36.5 22.7 <0.001c
African American,% 12.0 7.1 8.7 10.4 12.5 6.9 <0.001c
Smoking <0.001c
 No 81.3 60.6 76.0 82.1 85.1 86.6
 Yes 7.0 9.0 8.6 7.2 5.9 5.9
 Missing 11.7 30.4 15.4 10.7 9.0 7.6
BMI <0.001c
 <18.5 kg/m2 0.88 0.53 0.39 0.56 0.72 1.8
 18.5–24.9 kg/m2 20.4 13.4 13.6 15.8 20.7 32.1
 25–29.9 kg/m2 34.9 30.2 33.1 35.8 36.3 35.3
 30–34.9 kg/m2 22.8 25.2 27.3 24.3 22.6 17.1
 35–39.9 kg/m2 10.4 13.7 12.8 11.7 9.7 6.8
 >40 kg/m2 7.3 9.5 8.9 8.2 7.2 4.6
 Missing 3.4 7.6 3.9 3.6 2.7 2.3
eGFR, ml/min/1.73 m2 48.7+9.8 45.9+11.0 48.0+10.1 48.7+9.9 49.1+9.5 49.5+9.3 <0.001a
eGFR categories <0.001c
 45–59 71.5 61.2 68.9 71.5 73.3 74.5
 30–44 22.1 27.5 23.5 22.0 21.3 20.5
 15–29 6.4 11.3 7.6 6.4 5.4 5.0
Diabetes, % 29.8 32.4 37.8 33.2 27.9 20.8 <0.001c
Hypertension, % 87.2 66.1 83.6 88.6 90.2 91.5 <0.001c
CAD, % 24.2 26.3 30.9 26.4 23.0 17.3 <0.001c
CHF, % 7.8 11.2 9.9 7.8 6.4 6.5 <0.001c
Cerebrovascular
disease, % 10.4 8.4 10.6 10.8 10.8 9.9 0.002c
Peripheral vascular
disease, % 3.7 4.5 4.2 3.8 3.4 3.2 <0.001c
Hyperlipidemia, % 89.0 75.6 87.0 89.4 90.7 91.9 <0.001c
ACEI/ARBs, % 66.6 58.5 70.4 69.4 67.3 62.1 <0.001c
Statin use, % 65.8 52.6 66.3 69.2 69.3 61.9 <0.001c
Beta-Blocker use, % 55.7 56.4 62.1 57.9 55.2 48.5 <0.001c
Diuretic use, % 67.5 58.3 66.3 69.3 68.2 68.2 <0.001c
SBP (mm Hg) 130.2+19.0 127.5+20.2 129.5+19.2 130.0+19.0 130.4+18.7 131.1+18.7 <0.001a
DBP (mm Hg) 73.1+11.0 71.4+11.8 72.7+11.3 73.1+11.0 73.2+10.7 73.5+10.9 <0.001a
Serum albumin 4.1+0.44 3.8+0.61 4.1+0.45 4.1+0.42 4.2+0.39 4.2+0.39 <0.001a
Hemoglobin 13.0+1.7 12.7+2.0 13.1+1.9 13.1+1.8 13.0+1.6 12.9+1.5 <0.001a
Serum triglycerides 127.0[90.0,180.0] 175.0[118.0,263.0] 160.0[113.0,223.0] 138.0[100.0,187.0] 119.0[88.0,162.0] 97.0[73.0,131.0] <0.001b
Total cholesterol 179.9±45.0 150.5±49.4 164.6±42.1 175.6±42.0 184.3±41.9 199.9±42.0 <0.001a
LDL cholesterol 98.3±36.1 80.9±40.8 90.9±33.7 98.5±35.1 101.7±36.1 103.7±36.0 <0.001a
Proteinuria, % 24.8 34.4 29.1 25.1 22.6 20.1 <0.001c
Malignancy, % 18.6 14.9 18.1 18.8 19.8 18.9 <0.001c
Insurance <0.001c
 Medicaid 0.30 0.41 0.31 0.36 0.26 0.23
 Medicare 79.4 74.1 76.5 78.7 81.5 82.0
 Missing 3.4 6.2 3.7 3.5 3.1 2.7
 Other 16.9 19.3 19.5 17.5 15.2 15.1

Values presented as mean+SD, percent, or median [P25, P75]

a

ANOVA,

b

Kruskal-Wallis test,

c

Chi-square test